Johnson & Johnson has announced the launch of a new variant under its over-the-counter cough syrup Benadryl.
According to the company, with mucolytic and expectorant active ingredients, its unique triple action formula thins, loosens and expels phlegm, allowing consumers to get easy relief.
Mr Tushar Murdeshwar, Vice-President - Marketing, Consumer Division, Johnson & Johnson Ltd, said: “Benadryl is an iconic brand with a strong heritage within the Johnson & Johnson portfolio. With the new variant, Benadryl plans to expand its range of specialist solutions.’’
Mr Gautam Suri, General Marketing Manager, Consumer Division, Johnson & Johnson Ltd, said: “With the new product, J&J is taking its first step towards building a cough expert equity under Benadryl. Further innovations are planned under the brand.’’
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.